Dr. Tonu Esko, VP & Chief Business Officer, Estonian Genome Centre

Dr. Tonu Esko walks through the Estonian Biobank initiative and its efforts to implement pharmacogenomics at the national healthcare level, in the context of the Estonian digital ecosystem. In particular, Dr. Esko talks about two ongoing pilot projects that have been designed as prevention programs for cardiovascular diseases and breast cancer.

His presentation covers themes such as the collection of polygenic risk score data from biobank participants, ways of integrating PGx screening programs into the clinical setting, and public media strategies to sensitize public opinion among both the population and the clinicians on the benefits of pharmacogenomics.


Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
1 Dec. 2020
North America
University of Tartu
Dr. Tonu Esko, VP & Chief Business Officer, Estonian Genome Centre
Complex disease genomics
Watch Now
Personalized Medicine Based on Genetic Variants in Estonia
Dr. Lili Milani talks about the personalized medicine initiative that she’s been leading at the Estonian Biobank.